Cost analysis of in-patient cancer chemotherapy at a tertiary care hospital

Journal of Cancer Research and Therapeutics

Volumn 9, Issue 3, 2013, Pages 397-401

  Wani, Mohammad Ashraf ^a   Tabish, S A ^a   Jan, Farooq A ^a   Khan, Nazir A ^a   Wafai, Z A ^a   Pandita, K K ^a  

^a SHER I KASHMIR INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Cancer chemotherapy; cost analysis; in patient; medical oncology; unit cost

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; CANCER CHEMOTHERAPY; CLINICAL TRIAL; DRUG COST; HOSPITAL; HOSPITAL CARE; HOSPITAL COST; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MEDICAL FEE; TERTIARY HEALTH CARE;

ANTINEOPLASTIC AGENTS; COSTS AND COST ANALYSIS; HEALTH CARE COSTS; HUMANS; INPATIENTS; NEOPLASMS; TERTIARY HEALTHCARE;

EID: 84885590864     PISSN: 09731482     EISSN: 19984138     Source Type: Journal    
DOI: 10.4103/0973-1482.119314     Document Type: Article

References (14)

1. Stone MJ, Aronoff BE, Evans WP, Fay JW, Lieberman ZH, Matthews CM, et al. History of the Baylor Charles A. Sammons Cancer Center. Proc (Bayl Univ Med Cent) 2003;16: 30-58.
2. Park K. Epidemiology of chronic non-communicable diseases and conditions. In: Park's Text Book of Preventive and Social Medicine. 20th ed., Vol. 6. M/S Banarasi Das Bhanot Publishers, Jabalpur, MP, India; 2009. p. 332-5.
3. Sahni A. Cancer epidemiology. Health Adm 2005;17: 14-5.
4. Meropol NJ, Schulman KA. Cost of cancer care: Issues and implications. J Clin Oncol 2007;25: 180-6.
5. Adam T, Evans DB, Murray CJL. Cost Effectiveness and Resource Allocation. 2003;1:3. Available from: http://www.resource-allocation. com/content/1/1/3. [Last accessed on 2009 Aug 11].
6. Suda KJ, Motl SE, Kuth JC. Inpatient oncology. Length of stay and hospital costs: Implications for rising inpatient expenditures. J Appl Res 2006;6: 127.
7. Zavras A, Andreopoulos N, Katsikeris N, Zavras D, Cartsos V, Vamvakidis A. Oral cancer treatment costs in Greece and the effect of advanced disease. BMC Public Health 2002;2: 12.
8. Wodinsky HB, DeAngelis C, Rusthoven JJ, Kerr IG, Sutherland D, Iscoe N, et al. Re-evaluating the cost of outpatient cancer chemotherapy. CMAJ 1987;137: 903-6.
9. Tabish SA, Mustafa A, Rangrez RA. Hospital accounting based cost studies: Indian experience. J Acad Hosp Adm 2001;13: 7-9.
10. Jan FA, Pandita KK, Banday MA, Quadiri GJ, Quayoom Q, Najimi AM. Cancer patients: Economic burden of care and their quality of life. J Acad Hosp Adm 2007:19;30-4.
11. Nyman JV, Dorr RT, Hall GR. Escalating costs for cancer chemotherapy. Am J Hosp Pharm 1981;38: 1151-4.
12. Kesteloot K, Lievens Y, van der Schueren E. Improved management of radiotherapy departments through accurate cost data. Radiother Oncol 2000;55: 251-62.
13. Young DS, Sachais BS, Jefferies LC. The costs of disease. Clin Chem 2000;46: 955-66.
14. Neymark N, Adriaenssen I. The costs of managing patients with advanced colorectal cancer in 10 different European centres. Eur J Cancer 1999;35: 1789-95.